{"id":2085403,"date":"2023-10-31T14:34:01","date_gmt":"2023-10-31T18:34:01","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/pfizer-suffers-massive-quarterly-loss-as-covid-vaccines-and-paxlovid-doses-are-returned\/"},"modified":"2023-10-31T14:35:13","modified_gmt":"2023-10-31T18:35:13","slug":"pfizer-suffers-massive-quarterly-loss-as-covid-vaccines-and-paxlovid-doses-are-returned","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/pfizer-suffers-massive-quarterly-loss-as-covid-vaccines-and-paxlovid-doses-are-returned\/","title":{"rendered":"Pfizer&#8217;s COVID vaccines and Paxlovid doses returned, causing huge quarterly loss."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"float:left\"><div class=\"counts mashsbcount\">22<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fpfizer-suffers-massive-quarterly-loss-as-covid-vaccines-and-paxlovid-doses-are-returned%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2085403&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>Pfizer Reports Significant Losses as Demand for COVID Vaccines\u200d and Paxlovid Decreases<\/h2>\n<p>Pfizer, the pharmaceutical\u200d giant, experienced a substantial loss in the third\u2063 quarter, according to CNBC. The\u200d company&#8217;s earnings \u200ccall revealed a decrease in demand for its COVID-19 vaccines and the antiviral medication Paxlovid.<\/p>\n<p>The losses were \u200cattributed to a write-off of $5.6 billion, primarily due to Paxlovid and its vaccine, Comirnaty, as announced by Pfizer. Paxlovid accounted for $4.7 billion in losses, while the\u2064 mRNA vaccine contributed $900 million.<\/p>\n<p>Despite these losses, Pfizer reported a quarterly revenue of\u200d $13.2 billion, which was a 42 percent decrease compared\u2064 to the second quarter of 2022. The revenue generated from Pfizer&#8217;s COVID shots during July to \u2062September was $1.31 billion,\u200d a 70 percent decrease from the\u2063 previous year.<\/p>\n<p>Furthermore, sales \u200dof Paxlovid plummeted by 97 percent year-over-year. The company agreed to take back nearly 8 million unused courses of Paxlovid from the U.S. government, along with its vaccine inventory, \u200das reported by Reuters.<\/p>\n<blockquote>\n<p>\u201cOne-time items include\u2063 a \u200cnon-cash revenue reversal of \u200capproximately \u200d$4.2 \u2064billion related to the return of an estimated 7.9 million treatment \u2063courses of U.S. government \u2063 [emergency use authorization]-labeled Paxlovid expected in the \u200bfourth quarter of 2023 and \u200ba non-cash charge of $5.6 billion recorded to\u2062 Cost of Sales in the third quarter of 2023 for COVID products inventory write-offs and other charges,\u201d it said.<\/p>\n<\/blockquote>\n<p>Shares of Pfizer opened at $30.32 on Tuesday morning, a significant decrease from its record high of over $57 per share in December 2021. This\u200c marked the first time the company reported losses since 2019.<\/p>\n<p>The declining demand for vaccines\u2063 and \u200dCOVID \u2064treatments was attributed to &#8220;population-wide \u2063immunity,&#8221; according to Reuters. The annual \u200bvaccination rates have dropped sharply as population-wide immunity has increased.<\/p>\n<p>Pfizer\u2062 plans to reduce its operating costs through a\u200b $3.5 billion program announced prior to the reported losses. Despite the setbacks, the company expressed optimism about its non-COVID drugs, highlighting their strong performance in the \u2063third quarter of 2023.<\/p>\n<blockquote>\n<p>\u201cWe\u200b are encouraged by the strong performance of Pfizer\u2019s \u200dnon-COVID products in the third quarter of\u200d 2023, including significant contributions from new \u2063launches and robust year-over-year growth for several\u200d key in-line brands,\u201d Pfizer Chairman and CEO Albert Bourla said in a statement.<\/p>\n<p>Chief Financial Officer David Denton added, \u201cWe are extremely pleased by\u200b the strong 10% operational revenue growth of Pfizer\u2019s non-COVID products in the third quarter of 2023.\u201d<\/p>\n<\/blockquote>\n<hr>\n<h3>A Note from Our Founder:<\/h3>\n<p>Every morning, we at The Western Journal\u2062 wake up and pursue our mission of giving you the important information you need about what\u2019s happening in America.<\/p>\n<p><a href=\"https:\/\/www.paypal.com\/donate\/?hosted_button_id=BM6XAWRJ8NS7A&#038;utm_source=site&#038;utm_medium=westernjournalism&#038;utm_campaign=authorpitch\"><b>We can\u2019t do that without your \u200chelp<\/b><\/a>.<\/p>\n<p>America has been on\u2064 the\u2063 receiving end of false narratives. The purpose of these false narratives is to \u2062make you feel powerless. The Western Journal empowers you by breaking these\u2062 false narratives.<\/p>\n<p>But I wouldn\u2019t be honest with you today if I didn\u2019t let you know that the future \u2063of The Western Journal is in jeopardy \u2062 <a href=\"https:\/\/www.paypal.com\/donate\/?hosted_button_id=BM6XAWRJ8NS7A&#038;utm_source=site&#038;utm_medium=westernjournalism&#038;utm_campaign=authorpitch\"><span style=\"font-weight: 400\">without your help<\/span><\/a>.<\/p>\n<p>Silicon Valley and the Big Tech tyrants have \u200bdone everything they can to put The Western\u200b Journal out of business. Our faithful donors and subscribers have kept us going.<\/p>\n<p>If you\u2019ve never chosen to donate, let me be honest: <a href=\"https:\/\/www.paypal.com\/donate\/?hosted_button_id=BM6XAWRJ8NS7A&#038;utm_source=site&#038;utm_medium=westernjournalism&#038;utm_campaign=authorpitch\"><span style=\"font-weight: 400\">We need your help today<\/span><\/a>.<\/p>\n<p>Please don\u2019t \u200cwait one minute. <a href=\"https:\/\/www.paypal.com\/donate\/?hosted_button_id=BM6XAWRJ8NS7A&#038;utm_source=site&#038;utm_medium=westernjournalism&#038;utm_campaign=authorpitch\"><span style=\"font-weight: 400\">Donate right now<\/span><\/a>  \u2013 our situation in\u200b America is dire. \u200bOur country hangs by a thread, and The Western Journal stands for truth in this difficult \u2063time.<\/p>\n<p><b>Please stand with us by donating today.<\/b><\/p>\n<p>Floyd \u2064G. Brown<br \/>\nFounder of The\u2062 Western Journal<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/www.westernjournal.com\/pfizer-suffers-massive-quarterly-loss-covid-vaccines-paxlovid-doses-returned\/\">Pfizer Suffers Massive Quarterly Loss \u200bas COVID Vaccines and\u200d Paxlovid Doses \u2062Are Returned<\/a> appeared first on\u200d <a rel=\"nofollow\" href=\"https:\/\/www.westernjournal.com\">The \u200dWestern\u200c Journal<\/a>.<\/p>\n<p> <\/p>\n<h2> How did the\u2063 decline in demand for\u200c COVID-19 vaccines and Paxlovid impact Pfizer&#8217;s\u200d overall revenue?<\/h2>\n<p><span>  S:\/\/www.westernjournal.com\/category\/us-news\/&#8221;>US\u200d News<\/a>, <a href=\"https:\/\/www.westernjournal.com\/category\/world-news\/\">World \u200cNews<\/a>, <a href=\"https:\/\/www.westernjournal.com\/category\/politics\/\">Politics<\/a>,\u2063 <a href=\"https:\/\/www.westernjournal.com\/category\/opinion\/\">Opinion<\/a> and more. <a href=\"https:\/\/www.westernjournal.com\/subscribe\">Join us<\/a> in our mission and let&#8217;s rebuild a bright and prosperous \u2062future\u200b for America\u2064 together.<\/p>\n<p>The pharmaceutical giant Pfizer has reported significant losses in the third \u200cquarter\u2064 of 2023 due \u2062to a decrease \u2062in\u200b demand for its COVID-19 vaccines and the antiviral medication Paxlovid. The company&#8217;s earnings call revealed a write-off of $5.6 billion, primarily attributed to \u200cPaxlovid \u200cand\u2064 its vaccine Comirnaty.\u2064 The losses highlight the impact of declining demand for\u2062 COVID-related products and the challenges faced by pharmaceutical \u2063companies in adapting to changing market conditions.<\/p>\n<p>Pfizer recorded a\u2062 quarterly revenue of $13.2 billion, a 42 percent decrease compared to \u2063the\u200b previous quarter. This decline is \u2062largely driven by a 70 percent\u2062 decrease in revenue generated from Pfizer&#8217;s \u2063COVID shots during the third quarter of 2023, compared to the\u200d same period the previous year. Additionally,\u2064 sales of Paxlovid plummeted by 97 percent year-over-year, prompting \u200dPfizer to agree to take \u200cback\u2062 nearly 8 million unused courses of the \u200dmedication \u200dfrom the U.S. government.<\/p>\n<p>The declining demand for COVID-19 vaccines and treatments can be attributed to increasing population-wide immunity.\u200d As\u2062 vaccination rates have dropped sharply, the need for COVID-related products has decreased. This trend reflects a positive development in\u200b the battle\u2064 against the pandemic, but it poses\u200b challenges \u200dfor pharmaceutical companies that\u200b heavily rely on COVID-related sales.<\/p>\n<p>Despite these setbacks, Pfizer remains optimistic \u2062about its non-COVID drugs.\u200d The company highlighted the strong performance of its non-COVID products in the \u2063third\u200c quarter, with significant\u200d contributions from new \u200claunches and robust year-over-year growth for key in-line brands. Pfizer&#8217;s Chairman and CEO, Albert Bourla, expressed encouragement regarding the performance of their non-COVID products, signaling potential growth areas for the \u2062company.<\/p>\n<p>In response to the reported losses,\u200c Pfizer plans to reduce\u2063 its operating\u2063 costs through a $3.5 billion program announced prior to the earnings \u200bcall. This \u2062cost reduction strategy aims\u200d to \u2063optimize the company&#8217;s \u2062financial \u200bperformance and mitigate \u200bthe impact of declining COVID-related \u200bsales.<\/p>\n<p>The financial downturn experienced\u200c by Pfizer is notable as it marks the first reported losses for the company since 2019. The decrease in demand for COVID-19 vaccines \u2062and Paxlovid underscores the ongoing challenges \u2063faced by pharmaceutical companies in navigating the ever-changing landscape of the global health crisis.<\/p>\n<p>As Pfizer and other pharmaceutical companies adapt to shifting market dynamics, it remains crucial\u2063 to focus on the development of innovative non-COVID products that can sustain their revenue stream. The lessons learned from managing the COVID-19 pandemic can inform future strategies and help companies\u200d like Pfizer navigate future challenges in the \u2062healthcare industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer&#8217;s Q3 loss was revealed in an earnings call, with reduced demand for its COVID-19 vaccines and antiviral drug. CNBC reported a significant decrease in sales. The company incurred a $5.6 billion write-off for Paxlovid and Comirnaty vaccines. Paxlovid alone accounted for a $4.7 billion loss.<\/p>\n","protected":false},"author":2006,"featured_media":2085404,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[548],"tags":[],"class_list":["post-2085403","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conservative-news-daily"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2085403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/2006"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2085403"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2085403\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2085404"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2085403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2085403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2085403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}